Supreme Court on Wednesday declined to entertain Samajwadi Party leader Azam Khan's plea seeking to transfer certain cases against him from Uttar Pradesh to another state.
Amid the exponential rise in COVID-19 cases in China, the pharmaceutical industries are finding it difficult to cope with the high demand for medicines after the Xi Jinping-led government announced relaxations in its zero-Covid policy.
The national capital recorded fewer than 10 COVID cases for the second day in a row with 7 fresh infections, according to the Delhi Health Department on Tuesday.
According to Dr Rajeev Jayadevan, Co-chairman of the National IMA Covid task force, XBB.1.5 is an upgraded version of XBB, a recombinant sub-lineage of Omicron that was found a few months ago in multiple countries like Singapore and later in India.
In the last 24 hours, the number of Covid tests conducted was 1,51,186 which is also a substantial increase from 92,955 tests conducted in the previous 24 hours (January 1).
"In the last two weeks, there have been a lot of respiratory tract infections happening in the form of fever, cough, runny/blocked nose, body ache and headache," expert said.
Now mandatory pre-departure RT-PCR testing has been introduced for passengers arriving in India on all international flights from China, Singapore, Hong Kong, South Korea, Thailand and Japan. The test has to be conducted within 72 hrs prior to undertaking the journey, said the Union Minis
The Chief Minister directed the officers that Intensity Care Units should be functional in all districts and there should be no shortage of medicines, specialists and technicians.
India recorded 173 new Covid-19 cases in the last 24 hours, according to Health Ministry data. With the new cases, the number of active cases in India now stands at 2,670.